Work

Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058

Year: 2021

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Neuropsychopharmacology

DOI: 10.1038/s41386-021-01170-8

Authors: Pejman Sehatpour, Daniel C. Javitt, Heloise M. De Baun, Marlene Carlson, Anna Beloborodova, David H. Margolin, Mark B. L. Carlton, Nicola L. Brice, Joshua T. Kantrowitz

Institutions: Nathan Kline Institute for Psychiatric Research, New York State Psychiatric Institute, Columbia University

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, New York State Psychiatric Institute, National Institute of Mental Health

Awards: G3642610054, G4820202071, G4934699304, Early Cortical Processing in Schizophrenia

OpenAlex ID: W3164947526

FWCI: 2.526

Cites: 97

Cited by: 27

Related to: 10